ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias.

Mov Disord

Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, F-75013, Paris, France.

Published: January 2016

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724296PMC
http://dx.doi.org/10.1002/mds.26494DOI Listing

Publication Analysis

Top Keywords

adcy5 mutation
4
mutation carriers
4
carriers display
4
display pleiotropic
4
pleiotropic paroxysmal
4
paroxysmal day
4
day nighttime
4
nighttime dyskinesias
4
adcy5
1
carriers
1

Similar Publications

Chromosomal sub-microscopic imbalances, such as microdeletions and microduplications, are associated with multiple genetic disorders. Here, we illustrate microdeletion 3q13.33q21.

View Article and Find Full Text PDF
Article Synopsis
  • This research focuses on the role of the ADCY5 gene in glioblastoma (GBM), examining its expression, epigenetic changes, and how these factors impact patient prognosis.
  • ADCY5 was found to be downregulated in GBM tissues and cell lines, and its lower expression correlates with higher DNA methylation and poorer patient outcomes.
  • Restoring ADCY5 expression reduced GBM cell growth and migration, indicating its potential as a therapeutic target in combating GBM.
View Article and Find Full Text PDF

Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer.

Front Pharmacol

July 2024

Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Glucagon-like peptide-1 (GLP-1) has crucial impact on glycemic control and weight loss physiologically. GLP-1 receptor agonists have been approved for treatment of diabetes and obesity. Emerging evidence suggests that GLP-1 receptor agonists exert anticancer effect in tumorigenesis and development.

View Article and Find Full Text PDF

Mutation of mpv17 results in loss of iridophores due to mitochondrial dysfunction in tilapia.

J Hered

July 2024

Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Key Laboratory of Freshwater Fish Reproduction and Development (Ministry of Education), Key Laboratory of Aquatic Science of Chongqing, School of Life Sciences, Southwest University, Chongqing 400715, China.

Mpv17 (mitochondrial inner membrane protein MPV17) deficiency causes severe mitochondrial DNA depletion syndrome in mammals and loss of pigmentation of iridophores and a significant decrease of melanophores in zebrafish. The reasons for this are still unclear. In this study, we established an mpv17 homozygous mutant line in Nile tilapia.

View Article and Find Full Text PDF

Background: There is growing evidence that pathogenic mutations do not fully explain hypertrophic (HCM) or dilated (DCM) cardiomyopathy phenotypes. We hypothesized that if a patient's genetic background was influencing cardiomyopathy this should be detectable as signatures in gene expression. We built a cardiomyopathy biobank resource for interrogating personalized genotype phenotype relationships in human cell lines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!